PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, UCL, London, UK. Electronic address: a.cozzi-lepri@ucl.ac.uk.\', \'Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, UCL, London, UK.\', \'Department of Infectious Diseases, Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1198-743X(21)00620-010.1016/j.cmi.2021.10.018
?:doi
?:hasPublicationType
?:journal
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 34768021
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Signals were broadly positive for months, but never definitive: the tocilizumab story.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34768021>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34768021>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all